Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Species interactions are key to spatiotemporal gene expression and multilayer formation in <i>Stenotrophomonas maltophilia</i> K279a dual species biofilms.

Biofilm·2026
Same author

Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma.

Cancer cell·2026
Same author

Phosphinate or Urea? Synthesis and Biological Evaluation of Prostate Specific Membrane Antigen-Targeted Fluorophores With Different Zinc-Binding Motif.

ChemMedChem·2026
Same author

Engineered Coiled-Coils Convert Cholera Toxin B-Pentamers into Programmable Membrane Fusogens.

ACS nano·2026
Same author

Network-Based Prediction of Oligodendroglioma Driver Gene Candidates within the Region of the 1p/19q Co-deletion Utilizing Single-Cell Transcriptomes.

Computational and structural biotechnology journal·2026
Same author

Spin dynamics and long phase-memory times in structurally distinct non-oxido vanadium(IV) complexes with rigid ligand frameworks relevant to molecular qubits.

Dalton transactions (Cambridge, England : 2003)·2026

Related Experiment Video

Updated: Aug 30, 2025

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.9K

MARVEL domain containing CMTM4 affects CXCR4 trafficking.

Alexandra Bona1,2, Michael Seifert1, Roland Thünauer3,4

  • 1Renal Division and.

Molecular Biology of the Cell
|August 31, 2022
PubMed
Summary

The MARVEL protein CMTM4 regulates cell surface molecule trafficking, impacting cell migration and development. CMTM4

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.0K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.4K

Related Experiment Videos

Last Updated: Aug 30, 2025

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.9K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.0K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.4K

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Cancer Research

Background:

  • MARVEL proteins CMTM4 and CMTM6 are known regulators of PD-L1, influencing tumor immunity.
  • The precise molecular functions of CMTM4 beyond PD-L1 regulation remain incompletely understood.

Purpose of the Study:

  • To investigate the role of CMTM4 in cellular processes beyond PD-L1 regulation.
  • To elucidate the molecular mechanisms by which CMTM4 influences cell surface molecule trafficking and cell migration.

Main Methods:

  • Zebrafish posterior lateral line (pLL) development assays.
  • Mammalian cell culture experiments to study protein interactions and trafficking.
  • Analysis of protein glycosylation, internalization, degradation, and signaling pathways (AKT, ERK1/2).
  • Correlation analysis with patient survival data (TCGA cohort).

Main Results:

  • Defective zebrafish cmtm4 impaired pLL development by altering the Cxcr4b gradient.
  • CMTM4 interacts with CXCR4, modifying its glycosylation and slowing its trafficking from the endoplasmic reticulum to the plasma membrane.
  • CMTM4 affects ligand-induced CXCR4 degradation and influences AKT activation.
  • cmtm4 depletion in zebrafish embryos promoted cell separation from the pLL primordium.
  • CMTM4 expression correlated with improved survival in renal cell cancer patients.

Conclusions:

  • CMTM4 plays a significant role in the biosynthetic pathway of cell surface molecules.
  • CMTM4 influences CXCR4-dependent cell migration and developmental processes.
  • CMTM4 may have broader implications in cancer biology and patient outcomes.